Dr. Alan D. Friedman

M.D. | Pediatric Hematology-Oncology | Male

Dr. Alan D. Friedman, M.D. is a Baltimore, Maryland based Pediatric doctor with medical specialization in Pediatric Hematology-Oncology. Current practice location of Dr. Alan D. Friedman is 1650 Orleans St, Crb I, Rm. 270, Baltimore, Maryland - 21231-1000. He can be contacted on phone at 410-955-2095. Dr. Alan D. Friedman is a sole proprietor of his business.
NPI number (Unique professional ID) for Dr. Alan D. Friedman is 1760421812 which was assigned by NPPES on 05 Jun, 2006 and it was last updated on 30 Mar, 2023. Dr. Alan D. Friedman license number is D0033490 for Pediatrics, Pediatric Hematology-Oncology (2080P0207X) in Maryland.
Dr. Alan D. Friedman is trained in the combination of pediatrics, hematology and oncology to recognize and manage pediatric blood disorders and cancerous diseases.
Complete Profile:
Dr. Alan D. Friedman basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics, Pediatric Hematology-Oncology
Provider Name :Dr. Alan D. Friedman
Credential :M.D.
Gender :Male
Business Address:
Dr. Alan D. Friedman address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :1650 Orleans St, Crb I, Rm. 270
Baltimore, MD, 21231-1000
United States
Phone Number :410-955-2095
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1760421812
NPI Entity Type : Individual
First Enrolment Date : 05 Jun, 2006
Last Updated On : 30 Mar, 2023
Medicare Participation:
Dr. Alan D. Friedman participates in medicare and accepts medicare insurance either directly or through association with group practice or medical facility.
Medicare PECOS ID :4587709993
Medicare Enrollment ID :I20100309000552
Primary Specialty :Pediatric Medicine
Medical School :Harvard Medical School
Graduation Year :1983
Accepts Medicare?Yes. Dr. Alan D. Friedman accepts medicare insurance.
Group Practice Association:
Dr. Alan D. Friedman is associated with following Group Practice Organizations. Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name with which Dr. Alan D. Friedman is associated with along with the number of members in that group. He may also accept medicare indirectly via these group practices.
Organisation Name :Group Practice IDNo. of MembersPractice AddressGroup Accepts Medicare
Johns Hopkins University892190314726001800 Orleans St
Baltimore, MD - 212870010
Ph: 4109555000
Yes
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Alan D. Friedman are as mentioned. Primary taxonomy code for Dr. Alan D. Friedman, M.D. is 2080P0207X (Pediatrics, Pediatric Hematology-Oncology).
Taxonomy Code SpecialityPrimaryLicense No.State
2080P0207XPediatrics, Pediatric Hematology-OncologyYesD0033490MD
Legacy Identifiers:
Other legacy medical identifiers of Dr. Alan D. Friedman such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned below.
IdentifierIdentifier TypeStateIssuer
445741200MEDICAIDMD
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :6201 Greenleigh Ave
Middle River, MD, 21220-2004
United States
Phone Number :410-933-6423
Fax Number :410-500-4266
Business Location:
Patients can refer following map for directions to Dr. Alan D. Friedman practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.